/PRNewswire/ Synaffix B.V., a biotechnology company focused on commercializing its clinical-stage platform technology for the development of antibody-drug.
/PRNewswire/ Synaffix B.V., a biotechnology company focused on commercializing its clinical-stage platform technology for the development of antibody-drug.